An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Evolving Treatment Options for Relapsed/Refractory Follicular Lymphoma 0.75 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Optimizing First-Line Therapy for Diffuse Large B-Cell Lymphoma 0.75 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Novel Treatment Options for Hodgkin Lymphoma 0.75 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Diagnosis and Management of Secondary Hemophagocytic Lymphohistiocytosis 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Evolving Treatment Options for Low-Risk Myelodysplastic Syndromes 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Fertility Preservation in Hematologic Malignancies: Navigating Complex Choices 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Management of High-Risk Acute Promyelocytic Leukemia in the Community Setting 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Optimizing Cytoreductive Therapy for Polycythemia Vera 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Recorded Presentations from the NCCN 2025 Annual Congress: Hematologic Malignancies™ 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Archived NCCN Tumor Boards: Hereditary Gastrointestinal Cancers - Expansion of NCCN Recommendations 1.00 12/06/2025 - 12:00am to 12/01/2026 - 12:00am
NCCN Guidelines® Insights - Soft Tissue Sarcoma, Version 1.2025 1.00 12/10/2025 - 12:00am to 12/10/2026 - 11:59pm
Recorded Presentations from the NCCN 2025 Lung Cancer Congress 12/15/2025 - 12:00am to 11/06/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - Smoking Cessation: To Vape or Not to Vape? 1.00 12/18/2025 - 12:00am to 12/09/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - The Changing Treatment Paradigm for Mantle Cell Lymphoma: Improving the Prognosis with... 1.00 12/19/2025 - 12:00am to 12/17/2026 - 11:59pm
Steady Progress in Multiple Myeloma: Applying New Data and Updated Guidelines Throughout Treatment 2.00 12/19/2025 - 12:00am to 06/18/2026 - 11:59pm

Pages